AI & ChatGPT searches , social queriess for CD20
Search references for CD20. Phrases containing CD20
See searches and references containing CD20!
Search references for CD20. Phrases containing CD20
See searches and references containing CD20!CD20
Mammalian protein found in humans
B-lymphocyte antigen CD20 or CD20 is B lymphocyte cell-surface molecule. It is a 33-37 kDa non-glycosylated protein. CD20 is expressed on the surface of
CD20
Biopharmaceutical drug
newborn baby. Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. When it
Rituximab
Medication
Ofatumumab is a fully human monoclonal antibody to CD20, which appears to provide rapid B-cell depletion. Under the brand name Kesimpta, it is approved
Ofatumumab
Anti-CD20 monoclonal antibody
treatment of multiple sclerosis. It is a humanized anti-CD20 monoclonal antibody. It targets CD20 marker on B lymphocytes and is an immunosuppressive drug
Ocrelizumab
Bone marrow cancer in which lymphocytes are overproduced
lineage. CLL cells can express the typical B-cell markers such as CD19 and CD20, as well as abnormal surface markers such as CD5 and CD23. On a peripheral
Chronic_lymphocytic_leukemia
Medical condition
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a slow-growing CD20 positive form of Hodgkin lymphoma, a cancer of the immune system's B cells
Nodular lymphocyte predominant Hodgkin lymphoma
Nodular_lymphocyte_predominant_Hodgkin_lymphoma
Medication
Obinutuzumab, sold under the brand name Gazyva among others, is a humanized anti-CD20 monoclonal antibody used as a treatment for cancer and active lupus nephritis
Obinutuzumab
Monoclonal antibody
Odronextamab, sold under the brand name Ordspono, is a CD20 x CD3 bispecific monoclonal antibody that is used for the treatment of follicular lymphoma
Odronextamab
Reciprocating internal combustion engine
107 lb⋅ft) 1984–198? Nissan Stanza T11 (Belgium, possibly other markets) The CD20 family displaces 2.0 L (1,974 cc; 120.5 cu in), thanks to an increased bore
Nissan_CD_engine
relapsed or refractory non-Hodgkin lymphoma and Hodgkin lymphoma. In case of CD20-positive B cell lymphoid malignancies the ICE regimen is often combined today[when
ICE_(chemotherapy)
Type of blood and immune-system cancer
HL. For the other forms, although the traditional B-cell markers (such as CD20) are not expressed on all cells, Reed–Sternberg cells are usually of B cell
Hodgkin_lymphoma
Treatment for non-Hodgkin lymphoma
or Prednisolone, which are corticosteroids. Sometimes the chimeric anti-CD20 monoclonal antibody, rituximab, is added to this treatment regimen to form
CHOP_(chemotherapy)
Pharmaceutical compound
a cancer immunotherapy that targets CD20-positive B-cell malignancies. It is a fusion protein that combines a CD20 monoclonal antibody with the CD47 binding
Amulirafusp_alfa
Family of proteins
In molecular biology, the CD20-like family of proteins includes the CD20 protein and the beta subunit of the high affinity receptor for IgE Fc, MS4A2.
CD20-like_family
Medical treatment for lymphoma
[R]-MINE regimen consists of: Rituximab - anti-CD20 monoclonal antibody that can kill both normal CD20-expressing B cells and malignant ones; Mesna to
MINE_(chemotherapy)
Artificial stimulation of the immune system to treat cancer
that binds to CD20. It is used in the treatment of chronic lymphocytic leukemia (CLL) because the cancerous cells of CLL are usually CD20-expressing B-cells
Cancer_immunotherapy
Medication
treatment of diffuse large B-cell lymphoma. Epcoritamab is a bispecific CD20-directed CD3 T-cell engager. Epcoritamab was co-developed by AbbVie and Genmab
Epcoritamab
Medical intervention
chemotherapy and autologous stem cell transplantation. In combination with anti-CD20 monoclonal antibody rituximab (Rituxan, Mabthera) it is called R-DHAP or
DHAP_(chemotherapy)
Type of blood cancer
neoplastic cells in almost all cases of DLBCL, NOS express CD20. Commercially available anti-CD20 antibody agents such as rituximab or Obinutuzumab (which
Diffuse_large_B-cell_lymphoma
Medication used in cancer treatment
receptor (BCR). Additionally, ibrutinib down-modulates the expression of CD20 (target of rituximab/ofatumumab) by targeting the CXCR4/SDF1 axis. Together
Ibrutinib
Monoclonal antibody
autoimmune disorders. The antibody is engineered for enhanced affinity to the CD20 antigen on B-lymphocytes, increased antibody-dependent cell-mediated cytotoxicity
Ocaratuzumab
White blood cell that secretes large volumes of antibodies
antigens, and do not express common pan-B cell markers, such as CD19 and CD20. Instead, plasma cells are identified through flow cytometry by their additional
Plasma_cell
Combination medication
contains ocrelizumab, a recombinant humanized monoclonal antibody directed at CD20; and hyaluronidase (human recombinant), an endoglycosidase. It is taken by
Ocrelizumab/hyaluronidase
or GemOx-R, GEMOX-R. The [R]-GemOx regimen consists of: Rituximab - anti-CD20 monoclonal antibody that has the ability to kill both normal and malignant
GemOx
Type of cancer
antibodies for treatment of B-cell malignancies CD20. Approximately 95% of B-cell lymphomas express CD20, but CD20 is not critical for B-cell survival. Clonal
Germinal center B-cell like diffuse large B-cell lymphoma
Germinal_center_B-cell_like_diffuse_large_B-cell_lymphoma
Danish healthcare company
and commercialize ofatumumab, a drug that could be used for treatment in CD20 positive B-cell chronic lymphocytic leukemia, follicular non-Hodgkin’s lymphoma
Genmab
Medication
antibody used for the treatment of large B-cell lymphoma. It is a bispecific CD20-directed CD3 T-cell engager developed by Roche. The most common side effects
Glofitamab
Cell type associated with Hodgkin lymphoma
predominance type where they are negative, but are usually positive for CD20 and CD45. The presence of these cells is necessary in the diagnosis of Hodgkin
Reed–Sternberg_cell
Type of blood cancer
(that has not yet undergone the germinal center reaction), that is CD5, CD20, CD19 positive with expression of IgM and IgD with monoclonal kappa and gamma
Mantle_cell_lymphoma
Class of artificial monoclonal antibodies
relapsed or refractory acute lymphoblastic leukemia. It is a bispecific CD20-directed CD3 T-cell engager. It was approved for medical use in Canada in
T_cell_engager
Chemical compound
an immunomodulator used for the treatment of multiple sclerosis. It is a CD20-directed cytolytic monoclonal antibody. The most common adverse reactions
Ublituximab
Medical condition
immunoblasts in the remaining ~20% of cases. These malignant B lymphocytes express CD20 surface membrane protein in almost all cases, PD-1 surface membrane protein
Richter's_transformation
2007 greatest hits album by Sash!
CD1 to CD11, CD13 to CD20), Sascha Lappessen (tracks: CD1 to CD11, CD13 to CD20), Thomas Alisson (tracks: CD1 to CD11, CD13 to CD20) Music by Ralf Kappmeier
10th Anniversary (Sash! album)
10th_Anniversary_(Sash!_album)
Index of articles associated with the same name
company Genmab in trade names. Examples include: HuMax-CD4 (zanolimumab) HuMax-CD20 (ofatumumab) HuMax-EGFr (zalutumumab) This set index article includes a list
HuMax
Monoclonal antibody
Veltuzumab is a monoclonal antibody (targeted at CD20) which is being investigated for the treatment of non-Hodgkin's lymphoma. As of December 2011[update]
Veltuzumab
Chemotherapy regimen
[R]-FCM regimen contains Rituximab - anti-CD20 monoclonal antibody that can kill both normal and malignant CD20-bearing B cells; Fludarabine - an antimetabolite;
FCM_(chemotherapy)
Subtype of white blood cell
Gamma delta T cells Immunoregulation and cytotoxicity 5% (2–8%) TCRγδ and CD3 B cells Secretion of antibodies 23% (18–47%) MHC class II, CD19 and CD20
Lymphocyte
Chemical compound
or refractory marginal zone lymphoma who have received at least one anti-CD20-based regimen. In January 2023, the US Food and Drug Administration (FDA)
Zanubrutinib
Minivan
interior fittings are not the same as the 2.0 L petrol (SR20DE), 2.0 L diesel CD20 and turbo-diesel CD20T models manufactured in Japan for the local market
Nissan_Serena
Overview article
approved for primary progressive (PPMS) Ofatumumab (Kesimpta) is another anti-CD20 monoclonal antibody. Ublituximab (Briumvi) was approved for medical use in
Multiple sclerosis drug pipeline
Multiple_sclerosis_drug_pipeline
Hematologic cancer that affects lymphocytes
a pink histiocyte. By immunohistochemistry, the lymphoma cells expressed CD20, CD5, and Cyclin D1 (high-power view, H&E). Hodgkin lymphoma, nodular lymphocyte
Lymphoma
Services - Toledo State AirNav: I08 - Cabin Creek USFS Service Airport AirNav: CD20 - Sprague Airport The Telegraph: Which is the world's shortest airport runway
List_of_shortest_runways
Radioimmunotherapy treatment
camera, before the actual therapy is administered. The antibody binds to the CD20 antigen found on the surface of normal and malignant B cells (but not B cell
Ibritumomab_tiuxetan
Medical condition
monocytic (CD11b, CD11c) markers. Cells may aberrantly express B-cell marker CD20 and the NK marker CD56. Monoblasts may be positive for CD34.[citation needed]
Acute_monocytic_leukemia
Hematological malignancy
bone marrow. The hairy cells are larger than normal and positive for CD19, CD20, CD22, CD11c, CD25, CD103, and FMC7 antigens. (CD103, CD22, and CD11c are
Hairy_cell_leukemia
Dutch pharmaceutical company
made with the LEX System, BLX-301, a humanized and glyco-optimized anti-CD20 antibody for non-Hodgkin's B-cell lymphoma and other B-cell malignancies
Synthon_(company)
Group of disorders
cell surface membrane protein, CD30, the B cell surface membrane marker, CD20, and the proteins typical of the EBV replication cycle latency II or III
Epstein–Barr virus–associated lymphoproliferative diseases
Epstein–Barr_virus–associated_lymphoproliferative_diseases
Kei truck/microvan produced by Daihatsu
export versions generally received a torquier 843 cc three-cylinder engine (CD20), called the Daihatsu 850 Cab (S70 series). The 850 also benefitted from
Daihatsu_Hijet
Protein
It has been also shown that CXCR4 signalling regulates the expression of CD20 on B cells. Until recently, SDF-1 and CXCR4 were believed to be a relatively
CXCR4
Group of lymphomas
or the neoplastic large B cells in these lesions shows that they express CD20 but not CD3 surface membrane B cell marker proteins. The cells almost always
Marginal_zone_lymphoma
Medical condition
atypical CLL/SLL, and non-CLL/SLL phenotypes. These markers are: CD5, CD19, CD20, CD23, and immunoglobulins (Ig) (either Ig light chains or complete Ig, i
Monoclonal B-cell lymphocytosis
Monoclonal_B-cell_lymphocytosis
Pharmaceutical drug
immunosuppressants—especially those targeting B lymphocytes, such as anti-CD20 therapies—could increase the risk of severe infections. Likewise, combining
Belimumab
malignancies after allo SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion". Bone Marrow Transplantation. 43
List of therapeutic monoclonal antibodies
List_of_therapeutic_monoclonal_antibodies
American television personality (born 1973)
On April 30, 2009, Zohn was diagnosed with a rare type of cancer called CD20-positive Hodgkin's lymphoma. He started chemotherapy in May 2009. On September
Ethan_Zohn
Chronic blistering skin disease
the successful use of rituximab, an anti-CD20 monoclonal treatment, in managing this disease, other anti-CD20 drugs such as ocrelizumab, veltuzumab, and
Pemphigus_vulgaris
Pharmaceutical drug
Tositumomab is a murine monoclonal antibody which targets the CD20 antigen produced in mammalian cell. It was combined with iodine-131 to produce a radiopharmaceutical
Tositumomab
South Korean biopharmaceutical company
first biosimilar of the reference monoclonal antibody rituximab that targets CD20 molecule primarily found on the surface of B-cells. Its target indications
Celltrion
engine — 1.6/1.8/2.0 L — CA16, CA18i, CA18DE, CA18DET, CA18ET, CA20, CD17, CD20 (diesel) 1983–1987 Nissan FJ engine — 2.0/2.4 L — FJ20E, FJ20ET, FJ24 1983–1992
List_of_Nissan_engines
Motor vehicle
interior with GTR Skyline front seats. N1's available in Black, White and Red. CD20 — 2000 cc SOHC CRDi Diesel engine featured in the European Almera GX.[clarification
Nissan_Pulsar
Medical condition
manage disease symptoms. Rituximab is a monoclonal antibody therapy targeting CD20 that has been used to treat different forms of pemphigus reliably. In 2018
Pemphigus_erythematosus
Medical condition
killing CD20-bearing cell) to the intensive chemotherapy regimens used to treat Type I PEL: the malignant cells in Type II PEL commonly express CD20 whereas
Primary_effusion_lymphoma
Cancer of plasma cells
myeloma cells are often CD56, CD38, CD138, and CD319 positive and CD19, CD20, and CD45 negative. Flow cytometry is often used to establish the clonal
Multiple_myeloma
Medical condition
lymphoma from other small B-cell NHLs. B-cell-associated antigens such as CD19, CD20, CD22, and CD79a are usually expressed. In contrast to small lymphocytic
MALT_lymphoma
Monoclonal antibody
antibody used for the treatment of follicular lymphoma. It bispecifically binds CD20 and CD3 to engage T-cells. It was developed by Genentech. The most common
Mosunetuzumab
agreement with Wyeth for the development and worldwide commercialization of CD20-directed therapeutics. The agreement also included the development and worldwide
Trubion
Antibodies from clones of the same blood cell
rituximab non-Hodgkin's lymphoma rheumatoid arthritis targets phosphoprotein CD20 on B lymphocytes chimeric trastuzumab breast cancer with HER2/neu overexpression
Monoclonal_antibody
Genetically engineered T cell
2016, studies began to explore the viability of other antigens, such as CD20. Trials for solid tumors are less dominated by CAR T, with about half of
CAR_T_cell
Immunosuppressive drug
receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy". JAMA Neurology. 70 (3): 394–397. doi:10.1001/jamaneurol.2013.1246
Tocilizumab
Abnormal formation of clumps of inflammatory cells (granulomata)
diarrhea). Case reports have supported the efficacy of rituximab, an anti-CD20 monoclonal antibody and a clinical trial investigating atorvastatin as a
Sarcoidosis
Motor vehicle
the GA13DS and GA15DS versions for better emissions performance, the 2.0 L CD20 diesel engine was introduced with the ATTESA 4WD system, and ventilated front
Nissan_AD
CD14 (Monocytes), CD16 (NK cells, granulocytes), CD19 (B lymphocytes), CD20 (B lymphocytes), and CD56 (NK cells) in humans. Lineage markers include mitochondrial
Lineage_markers
CD5 CD6 CD7 CD8 a CD9 CD10 CD11 a b c d CD13 CD14 CD15 CD16 A B CD18 CD19 CD20 CD21 CD22 CD23 CD24 CD25 CD26 CD27 CD28 CD29 CD30 CD31 CD32 A B CD33 CD34
CNPY2
Motor vehicle
commercials came with either the 1.6 L GA16DS or the naturally aspirated CD20 2-liter diesel engine. The FWD was available with either a four-speed automatic
Nissan_Avenir
Intensive chemotherapy regimen
R-EPOCH or EPOCH-R. The R-EPOCH regimen consists of: Rituximab: an anti-CD20 monoclonal antibody, which has the ability to kill B cells, be they normal
EPOCH_(chemotherapy)
Chain reaction of white blood cell activation
reaction syndrome may also be induced by certain medications, such as the CD20 antibody rituximab and the CD19 CAR T cell tisagenlecleucel. The experimental
Cytokine_release_syndrome
Medical condition
rituximab in binding to CD20; two radioimmunotherapy monoclonal antibodies, Ibritumomab tiuxetan and Tositumomab that bind CD20 to deliver radiation from
Primary cutaneous diffuse large B-cell lymphoma, leg type
Primary_cutaneous_diffuse_large_B-cell_lymphoma,_leg_type
this regimen is called CEPP (B). With the further addition of the anti-CD20 monoclonal antibody rituximab, it is called R-CEPP(B). R-CEPP(B) regimen
CEPP
Natural premature termination of pregnancy
(February 28, 2022). "Immunohistochemical Evaluation of CD3, CD4, CD8, and CD20 in Decidual and Trophoblastic Tissue Specimens of Patients with Recurrent
Miscarriage
Medical intervention
status EMA status Ibritumomab tiuxetan (Zevalin) monoclonal antibody anti-CD20 conjugated to a molecule that chelates Yttrium-90. Approved (2002) Authorised
Radioimmunotherapy
Rare disease which results in brain inflammation
immunotherapy includes rituximab, a monoclonal antibody that targets the CD20 receptor on the surface of B cells, thus destroying the self-reactive B cells
Anti-NMDA receptor encephalitis
Anti-NMDA_receptor_encephalitis
Therapy using ionizing radiation, usually to treat cancer
Administration (FDA) approved ibritumomab tiuxetan (Zevalin), which is an anti-CD20 monoclonal antibody conjugated to yttrium-90. In 2003, the FDA approved the
Radiation_therapy
Membrane-spanning 4A genes are members of the CD20-like family. The MS4A genes are usually organized in a single genomic clusters in mammals, suggestive
Membrane-spanning_4A
Type of large B-cell lymphoma
express CD20 and often express CD45 marker proteins. While PBL plasmablastic cells weakly express CD20 in 10% of cases, the strong expression of CD20 and
Plasmablastic_lymphoma
Pharmaceutical drug classification
ATC code L01 Antineoplastic agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes
ATC_code_L01
American physician (born 1949)
clinical trial investigating rituximab, a monoclonal antibody targeting CD20+ B cells, which demonstrated efficacy in relapsing-remitting MS. A subsequent
Stephen_L._Hauser
Radioactive biochemical substance used for diagnosis or for study of receptor systems
murine monoclonal antibody) and binding/targeting the ligand CD20 on human B-cells. CD20 is a membrane spanning protein found on B-cell lymphocytes that
Radioligand
Immune disorder
in antibody production. Mutations in the genes encoding ICOS, TACI, CD19, CD20, CD21, CD80, and BAFFR have been identified as causative of CVID. Susceptibility
Common variable immunodeficiency
Common_variable_immunodeficiency
Activation or suppression of the immune system to treat disease
antibodies in cancer therapy was first introduced in 1997 with rituximab, an anti-CD20 antibody for treatment of B cell lymphoma. Since then several monoclonal
Immunotherapy
Medical condition
prednisolone) are usually given. Rituximab, a monoclonal antibody aimed at the CD20 molecule on B lymphocytes, may be used on diagnosis; this is thought to kill
Thrombotic thrombocytopenic purpura
Thrombotic_thrombocytopenic_purpura
Medical condition
corticosteroids and immunosuppressants. Biologic drugs, i.e. anti-TNFα or anti-CD20 monoclonal antibodies, have been recently introduced as alternative treatments
Overlap_syndrome
Autoimmune disease of skin and connective tissue characterized by large blisters
particularly in patients who cannot use corticosteroids.[citation needed] The anti-CD20 monoclonal antibody rituximab is effective in treating some otherwise refractory
Bullous_pemphigoid
Medical condition with rash and bleeding risk
rituximab, a chimeric monoclonal antibody against the B cell surface antigen CD20, may sometimes be an effective alternative to splenectomy. However, significant
Immune thrombocytopenic purpura
Immune_thrombocytopenic_purpura
Group of autoimmune diseases resulting in abnormal growth of connective tissue
dasatinib PO D (Au) As per imatinib Rituximab Monoclonal antibody against CD20, which is expressed on B lymphocytes IV C (Au) Infusion-related reactions
Scleroderma
U.S. House district for California
congressional district RAND California Election Returns: District Definitions California Voter Foundation map – CD20 36°N 120°W / 36°N 120°W / 36; -120
California's 20th congressional district
California's_20th_congressional_district
Car model and nameplate by Nissan
equipped with either a 1.4L GA14DE and 1.6L GA16DE petrol engine or a 2.0L CD20 diesel engine. Approximately one year into production, a 2.0L SR20DE GTi
Nissan_Almera
Medical condition
combination with other therapies. Rituximab is a monoclonal antibody targeting CD20-positive B cells (B cell markers) and has shown to benefit patients with
Baló_concentric_sclerosis
Medical analysis of disease
is averaged over (possibly five years), e.g. Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Chronic Lymphocytic Leukemia. When someone is interested
Survival_rate
Protein-coding gene in the species Homo sapiens
CD5 CD6 CD7 CD8 a CD9 CD10 CD11 a b c d CD13 CD14 CD15 CD16 A B CD18 CD19 CD20 CD21 CD22 CD23 CD24 CD25 CD26 CD27 CD28 CD29 CD30 CD31 CD32 A B CD33 CD34
Integrin_alpha_E
Former American biotechnology firm
made with the LEX System, BLX-301, a humanized and glyco-optimized anti-CD20 antibody for non-Hodgkin's B-cell lymphoma and other B-cell malignancies
Biolex
— February 2, 2005 Kitt Peak Spacewatch NYS 2.0 km MPC · JPL 117496 2005 CD20 — February 2, 2005 Catalina CSS · 4.1 km MPC · JPL 117497 2005 CL20 — February
List of minor planets: 117001–118000
List_of_minor_planets:_117001–118000
CD20
CD20
CD20
CD20
Girl/Female
Indian, Tamil
The Consort of God Krishna
Boy/Male
Hindu, Indian, Telugu
Glowness
Surname or Lastname
English
English : variant spelling of Joy.
Boy/Male
Arabic, Irish
Courteous; Variant of Shea
Male
Turkish
Turkish name ERDEM means "virtue."
Girl/Female
Indian, Sanskrit
Brightness
Girl/Female
Indian
Good deed, Kind act, Favor
Boy/Male
Muslim
Old Arabic name
Boy/Male
Tamil
Enter, Admission
Girl/Female
American, British, English
Pure; Keeper of the Keys
CD20
CD20
CD20
CD20
CD20